List of Tables
Table 1. Global TKIs for Breast Cancer Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global TKIs for Breast Cancer Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global TKIs for Breast Cancer Market Competitive Situation by Manufacturers in 2025
Table 4. Global TKIs for Breast Cancer Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global TKIs for Breast Cancer Sales Market Share by Manufacturers (2021–2026)
Table 6. Global TKIs for Breast Cancer Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global TKIs for Breast Cancer Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market TKIs for Breast Cancer Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of TKIs for Breast Cancer, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of TKIs for Breast Cancer, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of TKIs for Breast Cancer, Product Types and Applications
Table 12. Global Key Manufacturers of TKIs for Breast Cancer, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global TKIs for Breast Cancer Companies by Tier (Tier 1, Tier 2, Tier 3), based on TKIs for Breast Cancer Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global TKIs for Breast Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global TKIs for Breast Cancer Sales by Region (K Units), 2021–2026
Table 18. Global TKIs for Breast Cancer Sales Market Share by Region (2021–2026)
Table 19. Global TKIs for Breast Cancer Sales by Region (K Units), 2027–2032
Table 20. Global TKIs for Breast Cancer Sales Market Share by Region (2027–2032)
Table 21. Global TKIs for Breast Cancer Revenue by Region (US$ Million), 2021–2026
Table 22. Global TKIs for Breast Cancer Revenue Market Share by Region (2021–2026)
Table 23. Global TKIs for Breast Cancer Revenue by Region (US$ Million), 2027–2032
Table 24. Global TKIs for Breast Cancer Revenue Market Share by Region (2027–2032)
Table 25. North America TKIs for Breast Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America TKIs for Breast Cancer Sales by Country (K Units), 2021–2026
Table 27. North America TKIs for Breast Cancer Sales by Country (K Units), 2027–2032
Table 28. North America TKIs for Breast Cancer Revenue by Country (US$ Million), 2021–2026
Table 29. North America TKIs for Breast Cancer Revenue by Country (US$ Million), 2027–2032
Table 30. Europe TKIs for Breast Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe TKIs for Breast Cancer Sales by Country (K Units), 2021–2026
Table 32. Europe TKIs for Breast Cancer Sales by Country (K Units), 2027–2032
Table 33. Europe TKIs for Breast Cancer Revenue by Country (US$ Million), 2021–2026
Table 34. Europe TKIs for Breast Cancer Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific TKIs for Breast Cancer Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific TKIs for Breast Cancer Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific TKIs for Breast Cancer Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific TKIs for Breast Cancer Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific TKIs for Breast Cancer Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America TKIs for Breast Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America TKIs for Breast Cancer Sales by Country (K Units), 2021–2026
Table 42. Latin America TKIs for Breast Cancer Sales by Country (K Units), 2027–2032
Table 43. Latin America TKIs for Breast Cancer Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America TKIs for Breast Cancer Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa TKIs for Breast Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa TKIs for Breast Cancer Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa TKIs for Breast Cancer Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa TKIs for Breast Cancer Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa TKIs for Breast Cancer Revenue by Country (US$ Million), 2027–2032
Table 50. Global TKIs for Breast Cancer Sales (K Units) by Type (2021–2026)
Table 51. Global TKIs for Breast Cancer Sales (K Units) by Type (2027–2032)
Table 52. Global TKIs for Breast Cancer Sales Market Share by Type (2021–2026)
Table 53. Global TKIs for Breast Cancer Sales Market Share by Type (2027–2032)
Table 54. Global TKIs for Breast Cancer Revenue (US$ Million) by Type (2021–2026)
Table 55. Global TKIs for Breast Cancer Revenue (US$ Million) by Type (2027–2032)
Table 56. Global TKIs for Breast Cancer Revenue Market Share by Type (2021–2026)
Table 57. Global TKIs for Breast Cancer Revenue Market Share by Type (2027–2032)
Table 58. Global TKIs for Breast Cancer Price (US$/Unit) by Type (2021–2026)
Table 59. Global TKIs for Breast Cancer Price (US$/Unit) by Type (2027–2032)
Table 60. Global TKIs for Breast Cancer Sales (K Units) by Application (2021–2026)
Table 61. Global TKIs for Breast Cancer Sales (K Units) by Application (2027–2032)
Table 62. Global TKIs for Breast Cancer Sales Market Share by Application (2021–2026)
Table 63. Global TKIs for Breast Cancer Sales Market Share by Application (2027–2032)
Table 64. Global TKIs for Breast Cancer Revenue (US$ Million) by Application (2021–2026)
Table 65. Global TKIs for Breast Cancer Revenue (US$ Million) by Application (2027–2032)
Table 66. Global TKIs for Breast Cancer Revenue Market Share by Application (2021–2026)
Table 67. Global TKIs for Breast Cancer Revenue Market Share by Application (2027–2032)
Table 68. Global TKIs for Breast Cancer Price (US$/Unit) by Application (2021–2026)
Table 69. Global TKIs for Breast Cancer Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis TKIs for Breast Cancer Product
Table 74. Novartis Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GSK TKIs for Breast Cancer Product
Table 79. GSK Recent Developments/Updates
Table 80. Natco Pharma Company Information
Table 81. Natco Pharma Description and Business Overview
Table 82. Natco Pharma TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Natco Pharma TKIs for Breast Cancer Product
Table 84. Natco Pharma Recent Developments/Updates
Table 85. Lupin Pharmaceuticals Company Information
Table 86. Lupin Pharmaceuticals Description and Business Overview
Table 87. Lupin Pharmaceuticals TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Lupin Pharmaceuticals TKIs for Breast Cancer Product
Table 89. Lupin Pharmaceuticals Recent Developments/Updates
Table 90. Puma Biotechnology Company Information
Table 91. Puma Biotechnology Description and Business Overview
Table 92. Puma Biotechnology TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Puma Biotechnology TKIs for Breast Cancer Product
Table 94. Puma Biotechnology Recent Developments/Updates
Table 95. Beacon Pharma Company Information
Table 96. Beacon Pharma Description and Business Overview
Table 97. Beacon Pharma TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Beacon Pharma TKIs for Breast Cancer Product
Table 99. Beacon Pharma Recent Developments/Updates
Table 100. Drug International Company Information
Table 101. Drug International Description and Business Overview
Table 102. Drug International TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Drug International TKIs for Breast Cancer Product
Table 104. Drug International Recent Developments/Updates
Table 105. Jiangsu Hengrui Pharmaceuticals Company Information
Table 106. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 107. Jiangsu Hengrui Pharmaceuticals TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Jiangsu Hengrui Pharmaceuticals TKIs for Breast Cancer Product
Table 109. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 110. Seagen Company Information
Table 111. Seagen Description and Business Overview
Table 112. Seagen TKIs for Breast Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Seagen TKIs for Breast Cancer Product
Table 114. Seagen Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. TKIs for Breast Cancer Distributors List
Table 118. TKIs for Breast Cancer Customers List
Table 119. TKIs for Breast Cancer Market Trends
Table 120. TKIs for Breast Cancer Market Drivers
Table 121. TKIs for Breast Cancer Market Challenges
Table 122. TKIs for Breast Cancer Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of TKIs for Breast Cancer
Figure 2. Global TKIs for Breast Cancer Market Value by Type (US$ Million), 2021–2032
Figure 3. Global TKIs for Breast Cancer Market Share by Type: 2025 & 2032
Figure 4. lapatinib Product Picture
Figure 5. Neratinib Product Picture
Figure 6. Pyrotinib Product Picture
Figure 7. Tucatinib Product Picture
Figure 8. Other Product Picture
Figure 9. Global TKIs for Breast Cancer Market Value by Application (US$ Million), 2021–2032
Figure 10. Global TKIs for Breast Cancer Market Share by Application: 2025 & 2032
Figure 11. Hospital and Clinic
Figure 12. Retail Pharmacies
Figure 13. Other
Figure 14. Global TKIs for Breast Cancer Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global TKIs for Breast Cancer Market Size (US$ Million), 2021–2032
Figure 16. Global TKIs for Breast Cancer Sales (K Units), 2021–2032
Figure 17. Global TKIs for Breast Cancer Average Price (US$/Unit), 2021–2032
Figure 18. TKIs for Breast Cancer Report Years Considered
Figure 19. TKIs for Breast Cancer Sales Share by Manufacturers in 2025
Figure 20. Global TKIs for Breast Cancer Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global TKIs for Breast Cancer Players: Market Share by Revenue in TKIs for Breast Cancer in 2025
Figure 22. TKIs for Breast Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global TKIs for Breast Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America TKIs for Breast Cancer Sales Market Share by Country (2021–2032)
Figure 25. North America TKIs for Breast Cancer Revenue Market Share by Country (2021–2032)
Figure 26. United States TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe TKIs for Breast Cancer Sales Market Share by Country (2021–2032)
Figure 29. Europe TKIs for Breast Cancer Revenue Market Share by Country (2021–2032)
Figure 30. Germany TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific TKIs for Breast Cancer Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific TKIs for Breast Cancer Revenue Market Share by Region (2021–2032)
Figure 37. China TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America TKIs for Breast Cancer Sales Market Share by Country (2021–2032)
Figure 45. Latin America TKIs for Breast Cancer Revenue Market Share by Country (2021–2032)
Figure 46. Mexico TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa TKIs for Breast Cancer Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa TKIs for Breast Cancer Revenue Market Share by Country (2021–2032)
Figure 52. Turkey TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE TKIs for Breast Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of TKIs for Breast Cancer by Type (2021–2032)
Figure 56. Global Revenue Market Share of TKIs for Breast Cancer by Type (2021–2032)
Figure 57. Global TKIs for Breast Cancer Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of TKIs for Breast Cancer by Application (2021–2032)
Figure 59. Global Revenue Market Share of TKIs for Breast Cancer by Application (2021–2032)
Figure 60. Global TKIs for Breast Cancer Price (US$/Unit) by Application (2021–2032)
Figure 61. TKIs for Breast Cancer Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
